|
|
| About the manufacturer of
Meloxicam - Mobic |
Chicago pharmaceutical house namely Abbott Laboratories is
co-marketed with Boehringer Ingelheim develop MOBIC - Meloxicam.
They have a website that has more information: www.MOBICtablet.com.
Boehringer Ingelheim Pharmaceuticals, Inc. (1885-to date), based in
Ridgefield. The Boehringer Ingelheim group listed in world’s tope 20
leading pharmaceutical companies. Company’s headquarter is in
Ingelheim, Germany where Mobic - Meloxicam was developed, affiliated
with 152 agents in more than 45 countries. Company was found in 1885
and is still working with hard work and dedication; it has
approximately more than 34,500 employees who are devoted to do
research and keeping the production updated. Boehringer Ingelheim
Pharmaceuticals is consistent in both quality and quantity at the
same time.
They have been known to maintain good standards and good reputation
in the markets throughout the world for the manufacturing and
marketing of novel products for both human and animals, which are
highly beneficial and curative veterinary medicine. Company works by
embracing different cultures and diverse societies which made it a
global group; it makes Boehringer Ingelheim Pharmaceuticals
successful and independent.
The long term campaigns and short term precedence are possible when
working with an independent structure. More than US $8.47 billion
net sale is recorded in 2003 by Boehringer Ingelheim
Pharmaceuticals. It then spend one-sixth of the whole sale on
research and development sector in Prescription Medicine that
included the development of Mobic - Meloxicam. Boehringer Ingelheim
Pharmaceuticals is famous for the excellence in immunology,
cardiovascular and inflammatory disease researches and also have
many laboratories working for innovative medicines.
Web address is http://www.boehringer-ingelheim.com, and mailing
address is Boehringer Ingelheim GmbH, Corporate Headquarters: Binger
Str. 173, 55216 Ingelheim. Germany
|
|
